Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
Open Access
- 29 March 2023
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 90, 104545
- https://doi.org/10.1016/j.ebiom.2023.104545
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike proteinCell, 2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme ImmunoassaysViruses, 2021
- Evolution of antibody immunity to SARS-CoV-2Nature, 2021
- Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysisNature Communications, 2020
- Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2020
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesNature, 2020
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsCell, 2020
- Determination of 50% endpoint titer using a simple formulaWorld Journal of Virology, 2016
- Investigations of prion and virus safety of a new liquid IVIG productBiologicals, 2008